Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


24 diciembre 2013

STROKE. Brief Report. Predictors of Acute and Persisting Ischemic Brain Lesions in Patients Randomized to Carotid Stenting or Endarterectomy

Ayda Rostamzadeh, MD; Thomas Zumbrunn, PhD; Lisa M. Jongen, MD, PhD; Paul J. Nederkoorn, PhD, MD; Sumaira Macdonald, FRCR; Philippe A. Lyrer, MD; L. Jaap Kappelle, MD; Willem P. Th. M. Mali, MD; Martin M. Brown, FRCP; H. Bart van der Worp, PhD, MD; Stefan T. Engelter, MD; Leo H. Bonati, MD on behalf of the ICSS-MRI Substudy Investigators

Background and Purpose: We investigated predictors for acute and persisting periprocedural ischemic brain lesions among patients with symptomatic carotid stenosis randomized to stenting or endarterectomy in the International Carotid Stenting Study.

17 diciembre 2013

STROKE. Brief Report. Reperfusion Injury on Magnetic Resonance Imaging After Carotid Revascularization

A-Hyun Cho, MD, PhD; Yong-Pil Cho, MD, PhD; Deok Hee Lee, MD, PhD; Tae-Won Kwon, MD, PhD; Sun U. Kwon, MD, PhD; Dae-Chul Suh, MD, PhD; Jong S. Kim, MD, PhD; Dong-Wha Kang, MD, PhD

Background and Purpose: Reperfusion injury can be revealed as delayed gadolinium enhancement in the subarachnoid space on a fluid-attenuated inversion recovery image, which is designated as a hyperintense acute reperfusion marker (HARM). We sought to investigate the occurrence and predictors of HARM and its association with new ischemic infarcts after carotid revascularization.

16 octubre 2014

STROKE. Clinical Sciences. Evolution of Practice During the Interventional Management of Stroke III Trial and Implications for Ongoing Trials

Joseph P. Broderick, MD; Yuko Y. Palesch, PhD; Andrew M. Demchuk, MD; Sharon D. Yeatts, PhD; Pooja Khatri, MD; Michael D. Hill, MD; Edward C. Jauch, MD; Tudor G. Jovin, MD; Bernard Yan, MD; Rüdiger von Kummer, MD; Carlos A. Molina, MD; Mayank Goyal, MD; Mikael Mazighi, MD, PhD; Wouter J. Schonewille, MD; Stefan T. Engelter, MD; Craig Anderson, MD, PhD; Judith Spilker, RN, BSN; Janice Carrozzella, MSN, APRN, RT(R); L. Scott Janis, PhD; Lydia D. Foster, MS; Thomas A. Tomsick, MD; for the Interventional Management of Stroke III Investigators

Background and Purpose: We explored changes in the patient population and practice of endovascular therapy during the course of the Interventional Management of Stroke (IMS) III Trial.

25 noviembre 2014

STROKE. Clinical Sciences. Early Outcomes After Carotid Artery Stenting Compared With Endarterectomy for Asymptomatic Carotid Stenosis

Jay Chol Choi, MD; S. Claiborne Johnston, MD, PhD; Anthony S. Kim, MD, MAS

Background and Purpose: Despite the absence of definitive data from randomized clinical trials on the comparative effectiveness of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) for asymptomatic carotid stenosis, the use of CAS has been expanding and seems to be displacing the use of CEA in some parts of the United States.

08 agosto 2013

STROKE. Clinical Sciences. Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke

Amrou Sarraj, MD; Karen Albright, DO, MPH; Andrew D. Barreto, MD; Amelia K. Boehme, MSPH; Clark W. Sitton, MD; Jeanie Choi, MD; Steven L. Lutzker, MD; Chung-Huan J. Sun, MB; Wafi Bibars, MD; Claude B. Nguyen, MD; Osman Mir, MD; Farhaan Vahidy, MD; Tzu-Ching Wu, MD; George A. Lopez, MD, PhD; Nicole R. Gonzales, MD; Randall Edgell, MD; Sheryl Martin-Schild, MD, PhD; Hen Hallevi, MD; Peng Roc Chen, MD; Mark Dannenbaum, MD; Jeffrey L. Saver, MD; David S. Liebeskind, MD; Raul G. Nogueira, MD; Rishi Gupta, MD; James C. Grotta, MD; Sean I. Savitz, MD

Background and Purpose: Intra-arterial therapy (IAT) promotes recanalization of large artery occlusions in acute ischemic stroke. Despite high recanalization rates, poor clinical outcomes are common. We attempted to optimize a score that combines clinical and imaging variables to more accurately predict poor outcome after IAT in anterior circulation occlusions.

30 octubre 2013

STROKE. Clinical Sciences. Vasa Vasorum Enhancement on Computerized Tomographic Angiography Correlates With Symptomatic Patients With 50% to 70% Carotid Artery Stenosis

Javier M. Romero, MD; Raffaella Pizzolato, MD; Wendy Atkinson, BA; Anna Meader, BSc; Camilo Jaimes, MD; Glenn Lamuraglia, MD; Michael R. Jaff, DO; Ferdinando Buonanno, MD; Josser Delgado Almandoz, MD; Ramon G. Gonzalez, MD, PhD

Background and Purpose: Significant stenosis of the internal carotid artery (ICA) is an established stroke risk factor. Recent evidence suggests that features within the atherosclerotic plaque also have prognostic value. The purpose of this study was to correlate the enhancement of the vasa vasorum (VV) overlying the carotid artery plaque with acute neurological symptoms in patients with 50% to 70% ICA stenosis.

26 septiembre 2013

STROKE. Clinical Sciences. THRIVE Score Predicts Outcomes With a Third-Generation Endovascular Stroke Treatment Device in the TREVO-2 Trial

Alexander C. Flint, MD, PhD; Bin Xiang, PhD; Rishi Gupta, MD; Raul G. Nogueira, MD; Helmi L. Lutsep, MD; Tudor G. Jovin, MD; Gregory W. Albers, MD; David S. Liebeskind, MD; Nerses Sanossian, MD; Wade S. Smith, MD, PhD for the TREVO-2 Trialists

Background and Purpose: Several outcome prediction scores have been tested in patients receiving acute stroke treatment with previous generations of endovascular stroke treatment devices. The TREVO-2 trial was a randomized controlled trial comparing a novel endovascular stroke treatment device (the Trevo device) to a previous-generation endovascular stroke treatment device (the Merci device).

17 octubre 2013

STROKE. Clinical Sciences. A Clinical Rule (Sex, Contralateral Occlusion, Age, and Restenosis) to Select Patients for Stenting Versus Carotid Endarterectomy

Emmanuel Touzé, MD, PhD*; Ludovic Trinquart, PhD*; Rui Felgueiras, MD; Kittipan Rerkasem, MD, PhD; Leo H. Bonati, MD, PhD; Gayané Meliksetyan, MD; Peter A. Ringleb, MD, PhD; Jean-Louis Mas, MD; Martin M. Brown, MD, FRCP; Peter M. Rothwell, MD, PhD, FRCP, FMedSci in collaboration with the Carotid Stenting Trialists’ Collaboration

Background and Purpose: Compared with carotid endarterectomy (CEA), carotid angioplasty and stenting (CAS) is associated with a higher risk of procedural stroke or death especially in patients with symptomatic stenosis. However, after the perioperative period, risk is similar with both treatments, suggesting that CAS could be an acceptable option in selected patients.

30 octubre 2013

STROKE. Clinical Sciences. Does Sex Influence the Response to Intravenous Thrombolysis in Ischemic Stroke?

Svetlana Lorenzano, MD, PhD, MSc; Niaz Ahmed, MD, PhD; Anne Falcou, MD, PhD; Robert Mikulik, MD, PhD; Turgut Tatlisumak, MD, PhD; Christine Roffe, MD; Nils Wahlgren, MD, PhD; Danilo Toni, MD, PhD, FESO on behalf of the SITS Investigators

Background and Purpose: Women are more likely to have a worse outcome after an acute stroke than men. Some studies have suggested that women also benefit less from intravenous thrombolysis after an acute ischemic stroke, but others found no sex differences in safety and efficacy. We aimed to evaluate differences in 3-month outcome between sexes in intravenous tissue-type plasminogen activator–treated patients registered in the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register.

03 octubre 2013

STROKE. Brief Report. Extradural Internal Carotid Artery Caliber Dysregulation Is Associated With Cerebral Aneurysms

Sarah Schimansky, BSc; Samir Patel, BSc; Jason Rahal, MD; Alexandra Lauric, PhD; Adel M. Malek, MD, PhD

Background and Purpose: Flow-induced hemodynamic forces are critical in extra- and intracranial arterial caliber regulation and have been proposed to mediate intracranial aneurysm (IA) formation and rupture. We hypothesized that vascular structural control may be impaired in patients harboring brain aneurysms and sought to examine any differences in extradural internal carotid artery (ICA) caliber profiles.

17 octubre 2013

STROKE. Brief Report. Intracranial Stent Placement for Symptomatic Intracranial Stenosis as Part of a Clinical Trial Versus Outside a Clinical Trial

Farhan Siddiq, MD; Malik M. Adil, MD; Kiersten Norby, MD; Adnan I. Qureshi, MD

Background and Purpose: A high rate of postprocedure complications in the Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial has raised concerns whether such results are representative of intracranial stent placement in actual routine practice.

01 marzo 2014

AMERICAN JOURNAL OF ROENTGENOLOGY. Safety and Efficacy of Percutaneous Vertebroplasty and Interventional Tumor Removal for Metastatic Spinal Tumors and Malignant Vertebral Compression Fractures

Yi-Feng Gu1, Yong-Dong Li, Chun-Gen Wu, Zhen-Kui Sun and Cheng-Jian He

OBJECTIVE. The purpose of this study was to determine the safety and efficacy of percutaneous vertebroplasty and interventional tumor removal in the management of metastatic spinal tumors and malignant vertebral compression fractures.

01 enero 2014

RADIOLOGY. MR Selective Flow-Tracking Cartography: A Postprocessing Procedure Applied to Four-dimensional Flow MR Imaging for Complete Characterization of Cranial Dural Arteriovenous Fistulas

Myriam Edjlali, MD, Pauline Roca, PhD, Cécile Rabrait, PhD, Denis Trystram, MD, Christine Rodriguez-Régent, MD, Kevin M. Johnson, PhD, Oliver Wieben, PhD, Patrick Turski, MD, Jean-François Meder, MD, PhD, Olivier Naggara, MD, PhD, Catherine Oppenheim, MD, PhD

Cranial dural arteriovenous fistulas (DAVFs) are an uncommon but important cause of long-term morbidity and mortality, with an annual neurologic event rate of 15% (1). A DAVF is an abnormal direct connection between meningeal arteries and dural sinuses. High pressure in the sinus can result in both retrograde drainage into the venous sinus and retrograde cortical venous drainage. Digital subtraction angiography (DSA) is the standard of reference for the diagnosis and for tailoring the appropriate treatment by endovascular and/or surgical means. Apart from offering a high diagnostic performance in the detection of a DAVF, DSA enables the visualization of feeding arteries as well as the identification of the venous drainage pattern, including retrograde drainage into subarachnoid veins. The latter determines the grading of DAVF, which is important for estimating the risk of clinical complications. Importantly, the presence of retrograde cortical venous drainage or venous ectasia is considered a marker of high bleeding risk from DAVFs (1–3). However, DSA remains an invasive tool, with a potential risk, albeit very low, of severe periprocedural complications, and exposes both patients and medical staff to ionizing radiation (4). Numerous noninvasive imaging methods, such as time-resolved contrast material–enhanced magnetic resonance (MR) angiography (5) and susceptibility-weighted imaging (6,7), have demonstrated their value in the detection of DAVF. However, they all failed to enable the correct classification of DAVFs according to their bleeding risk on the basis of the Cognard classification (8). The major drawback of such MR investigations is that it is impossible to combine both optimized temporal and spatial resolution, which are necessary to appreciate the dynamic characteristics of a DAVF (eg, antegrade or retrograde venous flow) and to define precisely vessels involved in the DAVF. Accelerated four-dimensional (4D) flow imaging techniques based on phase-contrast MR imaging sequences open the possibility of capturing quantitative flow dynamics with high isotropic spatial resolution in a clinically acceptable acquisition time (9). We hypothesized that, by enabling global flow tracking in selected vessels (10), cartography of vessels implicated in cranial DAVFs could be performed. Our aim was to assess the feasibility of a selective flow-tracking cartographic procedure applied to 4D flow imaging and to demonstrate its usefulness in the characterization of DAVFs.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.